Methods of enhancing functioning of the large intestine
Assignee1149336 Ontario Inc.
InventorDaniel J. Drucker
Life of this patent
Estimating the term…
Abstract
The invention relates to glucagon-related peptides and their use for the prevention or treatment of disorders involving the large intestine. In particular, it has now been demonstrated that GLP-2 and peptidic agonists of GLP-2 can cause proliferation of the tissue of large intestine. Thus, the invention provides methods of proliferating the large intestine in a subject in need thereof. Further, the methods of the invention are useful to treat or prevent inflammatory conditions of the large intestine, including inflammatory bowel diseases.
Claims14
A method for treating a subject to enhance functioning of the large intestine, wherein the subject has undergone partial or subtotal resection of the large intestine, the method comprising the step of delivering to the large intestine of the subject a glucagon-like peptide-2 (GLP-2) receptor agonist in an amount effective to enhance functioning of the large intestine.
A method of treating a subject to proliferate the tissue of the large intestine, wherein the subject has undergone partial or subtotal resection of the large intestine, the method comprising the step of delivering to the large intestine of the subject a GLP-2 receptor agonist in an amount effective to proliferate the tissue of the large intestine.
Dependencies are inferred from the claim text.